Dear investors and partners,
Our community is actively discussing the transition to the next stage, that is closing the private funding round. I would like to make things clear and highlight the key points so that everyone has the full picture.
https://my.mlc.health/en/site/newsinfo/3286
First, this is not a marketing campaign.
The closing of the private funding round is not a promotional move or an attempt to boost sales. It is a real, timely and positive step for our project. We have reached the stage where the structure needs to be streamlined and the project needs to be ready to attract a major strategic investor. This serves the interests of all participants.
Second, there will be no extension.
The deadline for closing the private funding round will not be extended under any circumstances. This is not a "temporary restriction" or a "seasonal promotion". It is the end of the current stage. We therefore ask that you treat this matter with the utmost seriousness.
Third, we have come a long way together.
Since 2022, we have moved from an idea to a product. We continue to develop and refine our technologies, file patents, and have initiated the CE certification process; we are also close to setting up production in China. All of this has been possible thanks to your participation and trust.
What lies ahead?
A new stage. We will streamline the investor structure as part of preparations for attracting a major investor, and then move toward the public market. This will open up new opportunities for every participant: vested rights to shares, listing opportunities, and protection within a regulated framework.
We will keep you informed about every step via your personal office account and official channels.
Thank you for your support and trust. We have a great future ahead of us.
Sincerely,
Ivan Saltanov
CEO, MLC
